Vision Source and Med Tech Firm Heru Announce Commercial Partnership and Launch of re:Vive

By Staff
Monday, August 9, 2021 12:18 AM HOUSTON—Heru Inc., an innovator in vision diagnostics and augmentation platforms, announced a partnership with Vision Source, which will serve as the worldwide launch partner for re:Vive, the wearable diagnostic and visual field application, according to an announcement Friday.

FDA Clears Eyenuk's AI System for Diabetic Retinopathy Screening

By Staff
Tuesday, August 11, 2020 12:27 AM LOS ANGELES—Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and a leader in real-world applications for AI eye screening, has received the FDA’s 510(k) clearance (K200667) to market its EyeArt autonomous AI System for diabetic retinopathy, a leading cause of blindness among American adults.

Low-Cost Retinal Scanner Could Help Prevent Blindness Worldwide

By Staff
Monday, July 1, 2019 12:18 AM DURHAM, N.C.—Biomedical engineers at Duke University have developed a low-cost, portable optical coherence tomography (OCT) scanner that promises to bring the vision-saving technology to underserved regions throughout the U.S. and abroad. Thanks to a redesigned, 3D-printed spectrometer, the scanner is 15 times lighter and smaller than current commercial systems and is made from parts costing less than a tenth the retail price of commercial systems—all without sacrificing imaging quality. In its first clinical trial, the new OCT scanner produced images of 120 retinas that were 95 percent as sharp as those taken by current commercial systems, which was sufficient for accurate clinical diagnosis, according to Duke.

Remote Possibilities

By Andrew Karp
Monday, June 10, 2019 12:30 AM Many different forms of ocular telemedicine—also referred to as ocular telehealth—have emerged in the past few years. They create a dynamic but fragmented market in which different business models and service offerings compete for consumer dollars and buy-in from eyecare professionals. The proliferation of ocular telehealth options and the growing investment in the category leaves little doubt that it is gaining momentum, VM has learned for this special Megatrend report.